Metabolic Derangements in Acute Heart Failure Syndrome

Terminated

• Conditions: Congestive Heart Failure

• Registration Number: NCT00682175
• Lead Sponsor: The Cleveland Clinic

Brief Summary

To determine the association of both neurohormonal and hemodynamic alterations associated with metabolic abnormalities in acute heart failure syndrome.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-05
• Study First Submitted: 2008-05-20
• Study First Submitted QC: 2008-05-20
• Study First Posted: 2008-05-22
• Status Verified: 2009-03
• Primary Completion: 2009-03
• Study Completion: 2009-03
• Last Update Submitted: 2009-03-25
• Last Update Posted: 2009-03-26

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Adult (age > 18 yrs) patients admitted to the Heart Failure Intensive Care Unit (H22) with Acute Heart Failure Syndrome (AHFS) requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.

Exclusion Criteria

• History of Congenital Heart Disease.
• Acute HF in the setting of acute myocardial infarction.
• Severe Anemia
• Patients listed for cardiac transplantation.
• Terminal Malignancy, AIDS or CNS disease.
• Concomitant sepsis, ARDS, trauma, aortic dissection, or pericardial tamponade

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified